Welcome Message

Dear Colleagues and Friends,

On behalf of the Thai Society of Vascular and Interventional Radiology (TSVIR), it is our great pleasure to extend a warm and heartfelt invitation to you to join us for the 5th TSVIR Advanced Course Interventional Oncology, taking place from June 20th to 21st, 2025, at the @Nimman Convention Centre, Chiang Mai, Thailand.

This prestigious event promises a unique opportunity to explore the forefront of scientific innovation and clinical practice in vascular and interventional radiology. The program will feature insightful lectures, case discussions, and interactive sessions led by renowned experts in the field.

We are proud to welcome a distinguished audience that includes physicians, nurses, radiologic technologists, and other healthcare professionals dedicated to advancing patient care through interventional techniques.

Beyond the academic experience, Chiang Mai offers a rich cultural heritage, warm hospitality, and outstanding facilities that will make your stay both enjoyable and memorable.

We sincerely look forward to welcoming you to this exceptional scientific gathering and sharing meaningful conversations, knowledge, and collaboration in beautiful Chiang Mai, Thailand.

Assoc. Prof. Keerati Hongsakul, MD
President of TSVIR & Chairman of TSVIR 2025 Organizing committee

Registration

Registration fee (THB-Thai baht)
Category EARLY REGISTRATION
(21 April - 20 May)
LATE REGISTRATION
(21 May - 19 June)
Trainee (Resident, Fellow) 4,000 5,000
Doctor (Member) 5,000 6,000
Doctor (Non-member) 6,000 7,000
Nurse, Technologist, Others (Member) 4,000 5,000
Nurse, Technologist, Others (Non-member) 6,000 7,000

General Registration

Program Overview

@Nimman Convention Centre
Time Topics
8:45 - 9:00
Opening Ceremony and Welcome Speech

Assoc. Prof. Keerati Hongsakul
Asst. Prof. Tanop Srisuwan

Session 1 : Emerging Technologies in Imaging for Intervention Oncology
Moderator

Dr. Ching Charoenvisal
Asst. Prof. Thanate Kattipathanapong

9:00 - 9:20
Advanced in Ultrasound-Guided Interventions: Integration with Real-Time Imaging

Asst. Prof. Thanate Kattipathanapong

9:20 - 9:40
Cone Beam CT for Image-Guided Interventional Oncology: Capabilities and Advancements

Dr. Ching  Charoenvisal

9:40 - 10:00
CT Fluoroscopy: Basic Setup and Clinical Applications

Dr.Tanawin Tananankul

10:00 - 10:30
Break & Booth Round (1)

Dr. Sasikorn Feinggumloon

Session 2 : Miscellaneous in IO
Moderator

Dr. Ching Charoenvisal
Asst. Prof. Thanate Kattipathanapong

10:30 - 10:50
Cryoablation in Oncology: Cold over Heat

Asst. Prof.Satit Rojwatcharapibarn

10:50 - 11:10
Histotripsy for Solid Tumors: Mechanisms and Clinical Promise

Dr. Joseph Herman

11:10 - 11:30
Interventional Radiology in Thyroid Cancer: Is There a Place?

Dr. Lê Thị My

11:30 - 11:50
Recurrent and Metastatic Thyroid Cancer: The Role of IR - What, When and How?

Dr. Lê Thị My

12:00 - 13:00
Lunch Symposium Sponsored by Eisai : Maximize Benefit of Locoregional Treatment in Intermidiate-Stage HCC

Moderator Asst.Prof. Nutcha Pinjaroen

Enhancing Treatment Outcomes with TACE in Intermediate Stage HCC
Dr. Anucha Ahuya

New Treatment Paradigms for Intermediate Stage HCC Unsuitable for TACE
Assoc. Prof. Krittiya Korphaisan

 

Session 3 : Intervention Oncology in HCC
Moderator

Asst. Prof. Nakarin Inmutto,
Assoc.Prof. Kittipitch Bannangkoon

13:00 - 13:20
Current Surgical Candidates for HCC in the MDT Era

Assoc. Prof. Arnon Chotirosniramit

13:20 - 13:40
Toolbox for Liver Tumor Ablation: How to Choose?

Assoc. Prof. Somrach Thamtorawat

13:40 - 14:00
Four Decades of Lipiodol TACE: The Enduring Pillar in HCC Therapy

Assoc. Prof. Kittipitch Bannangkoon

14:00 - 14:20
DSM-TACE: Rethinking Temporary Embolization for Safety, Flexibility, and Enhanced Patient Outcomes

Adjunct Assoc. Prof. Pua Uei

14:20 - 14:40
New Frontier in Y90 Radioembolization

Prof. Pierce Chow 

14:40 - 15:10
Break & Booth Round (2)

Dr. Sasikorn Feinggumloon

15:10 - 15:30
GMD-cTACE: The Tiny Tool That Transforms TACE

Asst. Prof. Natthaphong Nimitrungtawee

15:30 - 15:50
DEB-TACE in HCC: Why and When Is HepaSphere Used?

Dr.Tharintorn Treesit

15:50 - 16:10
Integrating Radiation Therapy into Multidisciplinary Care for HCC

Dr. Napapat Amornwichet

16:10 - 16:30
Latest Updates on Dual Immunotherapy in HCC Treatment

Dr. Kunlatida Maneenil 

16:30 - 17:00
Panel Discussion: MDT - HBP vs Onco vs IR vs RT
Treatment Combination and Sequence in HCC

Asst. Prof. Nutcha Pinjaroen
Assoc. Prof. Arnon Chotirosniramit
Dr. Kunlatida Maneenil
Dr. Napapat Amornwichet